Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nishamalakichurna is a traditional Ayurvedic poly-herbal formulation composed of equal parts of *Curcuma longa* (turmeric) and *Emblica officinalis* (Indian gooseberry). It is primarily used in the management of Type 2 Diabetes mellitus, referred to in Ayurveda as Madhumeha. The formulation combines the anti-inflammatory and hypoglycemic properties of curcumin from turmeric with the antioxidant and glucose-regulating effects of vitamin C and tannins from Indian gooseberry. Clinical and experimental studies have evaluated its efficacy in controlling fasting blood sugar (FBS) and oral glucose tolerance (OGTT), often showing chronic effectiveness in glycemic control and reduction of oxidative stress markers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nishamalakichurna.